We're Out of TimeThe Future of Addiction Treatment Starts Here: GLP-1s Explained With Dr. Ken Spielvogel

One drug, four killers

21:53–24:51 · 178s

Dr. Spielvogel argues a weekly GLP-1 can reduce risks across cardiovascular disease, certain cancers, dementia, and diabetes, painting a sweeping case for their preventive power.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.